Table of Contents Author Guidelines Submit a Manuscript
Psychiatry Journal
Volume 2015, Article ID 575931, 6 pages
http://dx.doi.org/10.1155/2015/575931
Review Article

Evidence for Broadening Criteria for Atypical Depression Which May Define a Reactive Depressive Disorder

1Department of Psychology, City College of New York, New York, NY 10031, USA
2Research Unit, Zurich University Psychiatric Hospital, 8032 Zurich, Switzerland

Received 3 May 2015; Accepted 5 July 2015

Academic Editor: Yvonne Forsell

Copyright © 2015 Brett Silverstein and Jules Angst. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Publishing, Arlington, Tex, USA, 2013.
  2. J. Angst, A. Gamma, F. Benazzi et al., “Atypical depressive syndromes in varying definitions,” European Archives of Psychiatry and Clinical Neuroscience, vol. 256, no. 1, pp. 44–54, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. J. W. Stewart and M. E. Thase, “Treating DSM-IV depression with atypical features,” Journal of Clinical Psychiatry, vol. 68, no. 4, article e10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. E. D. West and P. J. Dally, “Effects of iproniazid in depressive syndromes,” The British Medical Journal, vol. 1, pp. 1491–1494, 1959. View at Google Scholar
  5. W. Sargant, “Drugs in the treatment of depression,” British Medical Journal, vol. 3, pp. 225–227, 1961. View at Google Scholar
  6. F. Quitkin, A. Rifkin, and D. F. Klein, “Monoamine oxidase inhibitors. A review of antidepressant effectiveness,” Archives of General Psychiatry, vol. 36, no. 7, pp. 749–760, 1979. View at Publisher · View at Google Scholar · View at Scopus
  7. F. M. Quitkin, J. W. Stewart, P. J. McGrath et al., “Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders,” The American Journal of Psychiatry, vol. 145, no. 3, pp. 306–311, 1988. View at Publisher · View at Google Scholar · View at Scopus
  8. E. S. Paykel, R. R. Parker, P. R. Rowan, B. M. Rao, and C. N. Taylor, “Nosology of atypical depression,” Psychological Medicine, vol. 13, no. 1, pp. 131–139, 1983. View at Publisher · View at Google Scholar · View at Scopus
  9. V. Henkel, R. Mergl, A.-K. Allgaier, R. Kohnen, H.-J. Möller, and U. Hegerl, “Treatment of depression with atypical features: a meta-analytic approach,” Psychiatry Research, vol. 141, no. 1, pp. 89–101, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Angst, A. Gamma, R. Sellaro, H. Zhang, and K. Merikangas, “Toward validation of atypical depression in the community: results of the Zurich cohort study,” Journal of Affective Disorders, vol. 72, no. 2, pp. 125–138, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. G. B. Parker, “Atypical depression: a valid subtype?” Journal of Clinical Psychiatry, vol. 68, no. 3, pp. 18–22, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Benazzi, “Can only reversed vegetative symptoms define atypical depression?” European Archives of Psychiatry and Clinical Neuroscience, vol. 252, no. 6, pp. 288–293, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. F. M. Quitkin, P. J. McGrath, J. W. Stewart et al., “Atypical depression, panic attacks and response to imipramine and phenelzine. A replication,” Archives of General Psychiatry, vol. 47, no. 10, pp. 935–941, 1990. View at Publisher · View at Google Scholar · View at Scopus
  14. J. W. Stewart, P. J. McGrath, F. M. Quitkin, and D. F. Klein, “Atypical depression: current status and relevance to melancholia,” Acta Psychiatrica Scandinavica, no. 433, pp. 58–71, 2007. View at Google Scholar · View at Scopus
  15. M. E. Thase, “Atypical depression: useful concept, but it's time to revise the dsm-iv criteria,” Neuropsychopharmacology, vol. 34, no. 13, pp. 2633–2641, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Silverstein, P. Cohen, and S. Kasen, “Should additional symptoms be included in criteria for atypical depression?” Psychiatry Research, vol. 144, no. 1, pp. 87–89, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Seemüller, M. Riedel, F. Wickelmaier et al., “Atypical symptoms in hospitalised patients with major depressive episode: frequency, clinical characteristics, and internal validity,” Journal of Affective Disorders, vol. 108, no. 3, pp. 271–278, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Pollitt and J. Young, “Anxiety state or masked depression? A study based on the action of monoamine oxidase inhibitors,” British Journal of Psychiatry, vol. 119, no. 549, pp. 143–149, 1971. View at Publisher · View at Google Scholar · View at Scopus
  19. P. F. Sullivan, R. C. Kessler, and K. S. Kendler, “Latent class analysis of lifetime depressive symptoms in the national comorbidity survey,” The American Journal of Psychiatry, vol. 155, no. 10, pp. 1398–1406, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Lamers, D. Rhebergen, K. R. Merikangas, P. De Jonge, A. T. F. Beekman, and B. W. J. H. Penninx, “Stability and transitions of depressive subtypes over a 2-year follow-up,” Psychological Medicine, vol. 42, no. 10, pp. 2083–2093, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Rodgers, V. Ajdacic-Gross, M. Müller et al., “The role of sex on stability and change of depression symptom subtypes over 20 years: a latent transition analysis,” European Archives of Psychiatry and Clinical Neuroscience, vol. 264, no. 7, pp. 577–588, 2014. View at Publisher · View at Google Scholar
  22. J. Davidson, R. Krishma, R. France, and S. Pelton, “Neurovegetative symptoms in chronic pain and depression,” Journal of Affective Disorders, vol. 9, no. 3, pp. 213–218, 1985. View at Publisher · View at Google Scholar · View at Scopus
  23. K. S. Kendler, L. J. Eaves, E. E. Walters, M. C. Neale, A. C. Heath, and R. C. Kessler, “The identification and validation of distinct depressive syndromes in a population-based sample of female twins,” Archives of General Psychiatry, vol. 53, no. 5, pp. 391–399, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. M. A. Posternak and M. Zimmerman, “The prevalence of atypical features across mood, anxiety, and personality disorders,” Comprehensive Psychiatry, vol. 43, no. 4, pp. 253–262, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Perugi, C. Toni, M. C. S. Passino, K. K. Akiskal, S. Kaprinis, and H. S. Akiskal, “Bulimia nervosa in atypical depression: the mediating role of cyclothymic temperament,” Journal of Affective Disorders, vol. 92, no. 1, pp. 91–97, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. A. A. Nierenberg, K. A. Phillips, T. J. Petersen et al., “Body dysmorphic disorder in outpatients with major depression,” Journal of Affective Disorders, vol. 69, no. 1–3, pp. 141–148, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Maj, “‘Psychiatric comorbidity’: an artefact of current diagnostic systems?” British Journal of Psychiatry, vol. 186, pp. 182–184, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. Z. Yao, R. Yan, M. Wei, H. Tang, J. Qin, and Q. Lu, “Gender differences in brain activity and the relationship between brain activity and differences in prevalence rates between male and female major depressive disorder patients: a resting-state fMRI study,” Clinical Neurophysiology, vol. 125, pp. 2232–2239, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. U. Halbreich and L. S. Kahn, “Atypical depression, somatic depression and anxious depression in women: are they gender-preferred phenotypes?” Journal of Affective Disorders, vol. 102, no. 1–3, pp. 245–258, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Silverstein, T. Edwards, A. Gamma, V. Ajdacic-Gross, W. Rössler, and J. Angst, “The role played by depression associated with somatic symptomatology in accounting for the gender difference in the prevalence of depression,” Social Psychiatry and Psychiatric Epidemiology, vol. 48, no. 2, pp. 257–263, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Silverstein, “The gender difference in depressive prevalence results from high prevalence among women of depression associated with somatic symptoms developing at adolescence in response to psychosocial issues,” in Affective Disorders: Epidemiology, Signs/Symptoms and Prognoses, L. D. Hambrick, Ed., Nova Science Publishers, Hauppauge, NY, USA, 2013. View at Google Scholar
  32. J. W. Stewart, P. J. McGrath, M. Fava et al., “Do atypical features affect outcome in depressed outpatients treated with citalopram?” International Journal of Neuropsychopharmacology, vol. 13, no. 1, pp. 15–30, 2010. View at Publisher · View at Google Scholar · View at Scopus